Uracil‐tegafur as an adjuvant for hepatocellular carcinoma
Kiyoshi Hasegawa(Bunkyo University), Masatoshi Makuuchi(Nagano Children's Hospital), Keiji Sano(Osaka National Hospital), Hiroshi Imamura(Shinshu University), Tadatoshi Takayama(Nihon University), Yutaka Matsuyama(The University of Tokyo), Yasuhiko Sugawara(Kumamoto University), Masayoshi Ijichi, Norihiro Kokudo(National Center for Global Health and Medicine)
Cited by 94
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k